Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the Impact of Gadolinium Injection on the Measurement of the QSM Signal

NCT04906941 is registered in ClinicalTrials.gov with Fondation Ophtalmologique Adolphe de Rothschild as lead sponsor.

NCT NCT04906941
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04906941 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the Impact of Gadolinium Injection on the Measurement of the QSM Signal
Lead sponsor
Fondation Ophtalmologique Adolphe de Rothschild
Phase
Observational
Overall status
Completed
Start date
January 21, 2022
Completion date
July 19, 2023
Enrollment
73 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

white matter disease